A monthly recap of the latest news about Alzheimer’s and dementia Lilly drug slows Alzheimer's by 35%, bolstering treatment approach An experimental Alzheimer's drug developed by Eli Lilly and Co (LLY.N) slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing what experts say is the strongest evidence yet
Irvine, Calif., April 24, 2022 – Alzheimer's Orange County has released new figures on the prevalence of dementia and mild cognitive impairment (MCI) in Orange County, shedding light on the scope and severity of these conditions in the local community. According to the data, more than 164,000 people in Orange County live with dementia or
As we age, we can experience changes in our physical and cognitive capabilities. However, some older adults have more memory or thinking problems than other adults at their age. This condition is called mild cognitive impairment (MCI). In Orange County over 164,000 people are living with dementia or MCI. Currently, research has not indicated one
A monthly recap of the latest news about Alzheimer’s and dementia Artificial Intelligence Approach May Help Detect Alzheimer's Disease from Routine Brain Imaging Tests Researchers have developed and validated a deep learning–based method to detect Alzheimer’s disease based on routinely collected clinical brain images. Read more here. Yale study sheds light on why women
Recently, the news of actor Bruce Willis’ frontotemporal dementia diagnosis made national headlines, but it also put the spotlight on a disorder many are unfamiliar with. What is frontotemporal dementia? According to the NIH, Frontotemporal disorders (FTD), sometimes called frontotemporal dementia is a rare form of dementia that tends to occur at a younger age
A monthly recap of the latest news about Alzheimer’s and dementia Study of green tea and other molecules uncovers new therapeutic strategy for Alzheimer’s Researchers have discovered how a molecule found in green tea breaks apart tangles of the protein tau, a hallmark of Alzheimer’s disease. Read more here. Estimates of amyloid
Understanding their reality As a person’s cognitive ability starts to decline, the reality they perceive can be very different from ours. Dementias like Alzheimer's disease can cause more than just memory loss. The disease can impact our speech, logic, emotions, behavior, and affect our brain in other ways. People with Alzheimer’s may not have the
A monthly recap of the latest news about Alzheimer’s and dementia Microphysiological systems: A promising new platform for Alzheimer’s drug development One of the biggest and most persistent challenges in the quest for effective Alzheimer’s disease and related dementias therapies is finding better models for preclinical drug development. Read more here. FDA Grants
Thinking of ways to be more productive or increase one’s activity is common for anyone planning new goals or resolutions—especially at the start of a new year. However, those caring for someone with Alzheimer's or another type of dementia may find that their loved one has new or increased feelings of apathy. If that’s something you’ve
A monthly recap of the latest news about Alzheimer’s and dementia New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows A team led by researchers at the University of Washington has developed a laboratory test that can measure levels of amyloid beta oligomers in blood samples. Read more here.
